Profile picture

Doctor Luis Eduardo Echeverria

Foundation Cardiovascular of Colombia, Floridablanca (Colombia)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Early prescription of quadruple medical therapy in acute decompensated heart failure: a propensity score-matched analysis
Presentation
Early prescription of quadruple medical therapy in acute decompensated heart failure: a propensity score-matched analysis
ESC TV Morning Show - 1 September  2025 - Day 4
Presentation
ESC TV Morning Show - 1 September 2025 - Day 4
Management of Chagas heart failure - now and next
Presentation
Management of Chagas heart failure - now and next
Chagas cardiomyopathy in Colombia: opportunities and challenges
Presentation
Chagas cardiomyopathy in Colombia: opportunities and challenges
Heart rate in heart transplant: should ivabradine take control?
Presentation
Heart rate in heart transplant: should ivabradine take control?
Predictors of Ischemic Stroke in a cohort of patients with Chagas Cardiomyopathy: the CLOT-Chagas study
Presentation
Predictors of Ischemic Stroke in a cohort of patients with Chagas Cardiomyopathy: the CLOT-Chagas study
ICARUS registry: findings from the first 1595 cases of acute decompensated heart failure in a single center in a latin american country.
Presentation
ICARUS registry: findings from the first 1595 cases of acute decompensated heart failure in a single center in a latin american country.
Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
Presentation
Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
Is the mortality of chronic chagas cardiomyopathy higher than cardiomyopathy due to other etiologies? A systematic review and meta-analysis
Presentation
Is the mortality of chronic chagas cardiomyopathy higher than cardiomyopathy due to other etiologies? A systematic review and meta-analysis
Early in-hospital initiation of SGLT2 inhibitors in acute decompensated heart failure
Presentation
Early in-hospital initiation of SGLT2 inhibitors in acute decompensated heart failure

ESC 365 is supported by